文献速递重症综合管理与镇静镇痛

持续性危重症的起病时机:多中心回顾性队列研究

Timing of onset of persistent critical illness: a multi-centre retrospective cohort study.
PubMed 文献 · Intensive Care Med · 2018-11-12
一句话结论在加拿大阿尔伯塔省12个ICU中,约六分之一患者于入ICU后中位9天(范围5–21天)进入持续性危重症阶段,其院内死亡率更高(23.9% vs 15.5%,OR 1.54)。

该多中心观察性队列研究纳入2012年6月至2014年12月加拿大阿尔伯塔省12个ICU收治的年龄大于14岁的17783例患者,主要终点为院内死亡率。研究者将入ICU时的预测因素分为既往特征组分和急性疾病组分,通过多方法统计及随机拆分队列建立风险评分,观察各组分对死亡预测能力的变化。急性疾病组分在入ICU时预测准确(AUC 0.861;95%CI 0.860–0.862),但预测能力逐渐丧失,9天后不再优于既往特征,此转变定义为持续性危重症起病,占队列16.1%(n=2856)。持续性危重症患者院内死亡率更高(23.9% vs 15.5%,OR 1.54;95%CI 1.43–1.67,p<0.001),并占用54.5%的ICU床日及36.3%的医院床日。

要点

  • 在存活且仍在ICU的患者中,急性疾病组分对死亡的预测能力在入ICU 9天后不再优于既往特征,此转变即持续性危重症起病。
  • 持续性危重症占队列16.1%(n=2856),各亚组转变时间在5至21天之间。
  • 持续性危重症患者院内死亡率为23.9%,非持续性危重症患者为15.5%(OR 1.54;95%CI 1.43–1.67,p<0.001)。
  • 持续性危重症患者占用54.5%的97844个ICU床日及36.3%的420119个医院床日。
  • 入ICU时急性疾病组分预测死亡的AUC为0.861(95%CI 0.860–0.862),但该预测能力随住院时间延长而逐渐丧失。

适用人群与场景

  • 加拿大阿尔伯塔省12个ICU于2012年6月至2014年12月收治的年龄大于14岁的所有患者,共17783例,中位年龄61岁(IQR 49–71),62%为男性,平均APACHE II评分19.0(7.9)。

诊断标准与关键阈值

  • 持续性危重症起病定义为:在存活且仍在ICU的患者中,急性疾病组分对院内死亡的预测能力不再优于既往特征组分的时间点;本队列中该时间点为入ICU后9天,各亚组范围5–21天。

研究设计与关键结果

  • 多中心观察性队列研究,纳入17783例患者,主要终点为院内死亡率,院内死亡率为16.8%。
  • 入ICU时急性疾病组分预测死亡的AUC为0.861(95%CI 0.860–0.862),9天后不再优于既往特征。
  • 持续性危重症占队列16.1%(n=2856),各亚组转变时间在5至21天之间。
  • 持续性危重症患者院内死亡率为23.9%,非持续性危重症患者为15.5%(OR 1.54;95%CI 1.43–1.67,p<0.001)。
  • 持续性危重症患者占用54.5%的97844个ICU床日及36.3%的420119个医院床日。

证据类型、等级与局限

  • 证据类型:多中心观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,持续性危重症在阿尔伯塔省ICU收治的患者中约六分之一发生,提示死亡风险增加、ICU及住院时间延长,并 disproportionate 使用医疗资源。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Persistent critical illness has been described as a subtype of chronic critical illness, characterized as a transition after ICU admission where primary diagnosis and illness acuity are no better at predicting outcome than pre-hospital characteristics. Herein we describe the occurrence and outcomes associated with persistent critical illness in a large Canadian health region.

METHODS: In this multi-center observational cohort study, all patients aged older than 14 years admitted to 12 ICUs in Alberta, Canada, between June 2012 and December 2014 were included. Primary outcome was in-hospital mortality. Predictors at ICU admission were separated into: (1) antecedent characteristics component (e.g., demographics, chronic health component of the APACHE II score, comorbid conditions); and (2) acute illness component (e.g., APACHE II score at admission, SOFA score, primary diagnostic category, surgical status, acute organ support). Using multiple statistical methods and randomly splitting the cohort into development and validation samples for risk scoring using logistic regression, we examined mortality prediction of each of these components to characterize the timing of transition to persistent critical illness.

RESULTS: We included 17,783 patients with a median (IQR) age 61 years (49-71), 62% were male, and mean APACHE II score was 19.0 (7.9). In-hospital mortality was 16.8%. Among patients alive and in ICU, the acute illness component, which accurately predicted outcome at the time of admission [area under the receiver operating characteristics curve (AUC) 0.861; 95% CI 0.860-0.862], progressively lost predictive ability and was no longer more predictive than antecedent characteristics after 9 days. This transition defined the onset of persistent critical illness and comprised 16.1% (n = 2856) of the cohort. Transition ranged between 5 and 21 days across subgroups. In-hospital mortality was greater for those with persistent critical illness [23.9% vs. 15.5%, odds ratio (OR) 1.54; 95% CI 1.43-1.67, p < 0.001]. Persistently critically ill patients accounted for 54.5% of 97844 ICU bed-days and 36.3% of 420119 hospital bed-days, respectively.

CONCLUSIONS: Persistent critical illness occurred in one in six patients admitted to Alberta ICUs and portended greater risk of death, prolonged ICU and hospital stay, and disproportionate use of health resources compared to patients without persistent critical illness.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Bagshaw SM, Stelfox HT, Iwashyna TJ, et al. Timing of onset of persistent critical illness: a multi-centre retrospective cohort study. Intensive Care Med. 2018. PMID: 30421256. doi:10.1007/s00134-018-5440-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。